Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial.

Authors:
Leclercq C; Burri H; Delnoy PP; Rinaldi CA; Sperzel J and 6 more

Journal:
Europace

Publication Year: 2023

DOI:
10.1093/europace/euad294

PMCID:
PMC10561537

PMID:
37776313

Journal Information

Full Title: Europace

Abbreviation: Europace

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: Dr. Leclercq has received honoraria from Abbott, Medtronic, Boston Scientific, Biotronik, and Livanova. Dr. Burri has received institutional fellowship support and research grants from Abbott. Dr. Delnoy serves as a consultant to Abbott. Dr. Rinaldi has received research grants and honoraria from Abbott. Dr. Sperzel serves as a consultant to Abbott, in addition to receiving honoraria and currently conducting research sponsored by Abbott. Dr. Calò has none declared. Dr. Joaquin Fernandez Concha serves as a consultant to Abbott, Dr. Antonio Fusco has nothing to disclose. Dr. Faisal Al Samadi has received honoraria from Abbott, Medtronic, and Boston Scientific. Dr. Lee is an employee of Abbott. Dr. Thibault has received research support and honoraria from Abbott and Medtronic."

Evidence found in paper:

"Funding This study is sponsored by Abbott (ClinicalTrials.gov Identifier: NCT02006069)"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025